Dr. Miguel A Fernandez, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 30 Gorham St, Lowell, MA 01852 Phone: 978-452-4223 Fax: 978-452-1511 |
Central Street Chiropractic, Corp. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 191 Central St, Lowell, MA 01852 Phone: 978-441-0600 |
Dr. Paul Daigle, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 191 Central St, Lowell, MA 01852 Phone: 978-441-0600 |
Thomas M Rupley, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 287 Appleton, Lowell, MA 01852 Phone: 978-452-2727 Fax: 978-970-1432 |
Mill City Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 77 E Merrimack St, Suite 6, Lowell, MA 01852 Phone: 978-323-4441 Fax: 978-323-4401 |
Dr. Raul E Velez, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 154 Merrimack St, Lowell, MA 01852 Phone: 978-452-5807 Fax: 978-452-0130 |
News Archive
Leading critical care experts will discuss new techniques for assessing risk of acute kidney injury (AKI) at an educational symposium to be held at the Eighteenth International Conference on Continuous Renal Replacement Therapies (CRRT) in San Diego.
ook Regentec, Cook Group's first company in Indianapolis, cut the ribbon Wednesday on its new facility on Indiana Avenue and announced a collaboration with Indiana University School of Medicine aimed at developing tools and technologies that advance solutions in the emerging areas of immunotherapy, precision medicine, drug delivery, regenerative medicine and bioprinting.
Stringing the lights, storming the malls and all those parties! Imagine facing these holiday demands while you're tired, sick, sad and worried: for people with cancer or other life-threatening illnesses, this time of year can often be far from merry.
Progestins are used in hormone replacement therapies to counteract the negative effects of estrogen on the uterus and reduce the risk of uterine cancer. However, evidence in recent studies and clinical trials has demonstrated that progestins increase the risk of breast cancer. Now, University of Missouri researchers have compared four types of progestins used in hormone replacement therapies and found significantly different outcomes on the progression of breast cancer in an animal model depending on the type of progestins used.
› Verified 6 days ago